Literature DB >> 19509025

The impact of arteriovenous fistulas on aortic stiffness in patients with chronic kidney disease.

Mihai S Utescu1, Amélie LeBoeuf, Nadia Chbinou, Simon Desmeules, Marcel Lebel, Mohsen Agharazii.   

Abstract

BACKGROUND: The creation of arteriovenous fistulas (AVF) in patients with advanced chronic kidney disease (CKD) has been shown to have adverse effects on their central pulse wave profile suggesting a likely increase in arterial stiffness. The aim of the present study was to directly evaluate the effect of AVF on arterial stiffness. Method. Thirty-one stage-5 CKD patients underwent haemodynamic assessment prior to and 3 months after creation of AVF. Haemodynamic assessment included measurement of blood pressure (BP), central and carotidal pulse wave profile analysis, and carotido-femoral and carotido-radial pulse wave velocities (PWV). Pre-AVF and post-AVF haemodynamic parameters were compared using the Wilcoxon signed-rank test or the paired Student t-test as appropriate. Pearson correlations, single and multiple linear regressions, were used to determine the association between variables.
RESULTS: After creation of AVF, peripheral and central BPs decreased without significant change in heart rate (HR) or pulse pressure. Carotido-femoral PWV ((c-f)PWV) fell from 13.2 +/- 4.1 to 11.7 +/- 3.1 m/s (P < 0.001). There was an increase in the central augmentation index (20.8% +/- 11.5 versus 23.7% +/- 11.6, P = 0.07) of borderline significance, and a significant reduction in the subendocardial viability ratio (153% +/- 34 versus 143% +/- 32, P < 0.05), which was mainly the result of a decrease in the diastolic pressure time index (DPTI) without any significant change in the diastolic duration. The reduction of (c-f)PWV was explained by changes in mean BP and HR (R(2) = 0.29). The reduction in DPTI was related to changes in central diastolic BP and changes in end-systolic BP (adjusted R(2) = 0.87). The significant improvement in aortic stiffness was mostly the result of the relative reduction of (c-f)PWV in the subgroup of patients with baseline (c-f)PWV above the median value of 13 m/s.
CONCLUSION: The creation of AVF is associated with a passive improvement of aortic stiffness especially in patients with stiffer arteries. This improvement in arterial stiffness could potentially be beneficial to the cardiovascular system despite an associated deterioration in the aortic pulse wave profile.

Entities:  

Mesh:

Year:  2009        PMID: 19509025     DOI: 10.1093/ndt/gfp276

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  10 in total

1.  Effect of the arteriovenous access for hemodialysis on subendocardial viability ratio, pulse pressure and hospitalizations.

Authors:  Ricardo Senos Vizinho; Catarina Santos; Carlos Lucas; Teresa Adragão; José Diogo Barata
Journal:  J Nephrol       Date:  2014-03-06       Impact factor: 3.902

2.  Arteriovenous Fistula Creation and Estimated Glomerular Filtration Rate Decline in Advanced CKD: A Matched Cohort Study.

Authors:  Marie-Ève Dupuis; Louis-Philippe Laurin; Rémi Goupil; Valérie Bénard; Maude Pichette; Jean-Philippe Lafrance; Naoual Elftouh; Vincent Pichette; Annie-Claire Nadeau-Fredette
Journal:  Kidney360       Date:  2020-11-19

3.  Role of vascular function in predicting arteriovenous fistula outcomes: an observational pilot study.

Authors:  Jennifer M MacRae; Sofia Ahmed; Brenda Hemmelgarn; Yichun Sun; Billie-Jean Martin; Idan Roifman; Todd Anderson
Journal:  Can J Kidney Health Dis       Date:  2015-05-04

4.  Effects of Arteriovenous Fistula on Blood Pressure in Patients With End-Stage Renal Disease: A Systematic Meta-Analysis.

Authors:  Sean S Scholz; Davor Vukadinović; Lucas Lauder; Sebastian Ewen; Christian Ukena; Raymond R Townsend; Stefan Wagenpfeil; Michael Böhm; Felix Mahfoud
Journal:  J Am Heart Assoc       Date:  2019-02-19       Impact factor: 5.501

5.  Prehemodialysis arteriovenous access creation is associated with better cardiovascular outcomes in patients receiving hemodialysis: a population-based cohort study.

Authors:  Cheng-Chieh Yen; Mei-Yin Liu; Po-Wei Chen; Peir-Haur Hung; Tse-Hsuan Su; Yueh-Han Hsu
Journal:  PeerJ       Date:  2019-04-03       Impact factor: 2.984

6.  A Systematic Review and Meta-analysis of Nonpharmacologic-based Interventions for Aortic Stiffness in End-Stage Renal Disease.

Authors:  Rosendo A Rodriguez; Richard Hae; Matthew Spence; Beverley Shea; Mohsen Agharazii; Kevin D Burns
Journal:  Kidney Int Rep       Date:  2019-05-22

7.  Increased Excess Pressure After Creation of an Arteriovenous Fistula in End-Stage Renal Disease.

Authors:  Mathilde Paré; Rémi Goupil; Catherine Fortier; Fabrice Mac-Way; François Madore; Bernhard Hametner; Siegfried Wassertheurer; Martin G Schultz; James E Sharman; Mohsen Agharazii
Journal:  Am J Hypertens       Date:  2022-02-01       Impact factor: 2.689

8.  Association between vascular access creation and deceleration of estimated glomerular filtration rate decline in late-stage chronic kidney disease patients transitioning to end-stage renal disease.

Authors:  Keiichi Sumida; Miklos Z Molnar; Praveen K Potukuchi; Fridtjof Thomas; Jun Ling Lu; Vanessa A Ravel; Melissa Soohoo; Connie M Rhee; Elani Streja; Kunihiro Yamagata; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Nephrol Dial Transplant       Date:  2017-08-01       Impact factor: 5.992

9.  Vascular accesses for haemodialysis in the upper arm cause greater reduction in the carotid-brachial stiffness than those in the forearm: study of gender differences.

Authors:  Daniel Bia; Edmundo I Cabrera-Fischer; Yanina Zócalo; Cintia Galli; Sebastián Graf; Rodolfo Valtuille; Héctor Pérez-Cámpos; María Saldías; Inés Alvarez; Ricardo L Armentano
Journal:  Int J Nephrol       Date:  2012-04-08

10.  The impact of haemodialysis arteriovenous fistula on haemodynamic parameters of the cardiovascular system.

Authors:  Carlo Basile; Luigi Vernaglione; Francesco Casucci; Pasquale Libutti; Piero Lisi; Luigi Rossi; Valentina Vigo; Carlo Lomonte
Journal:  Clin Kidney J       Date:  2016-07-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.